U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 040484
Company: AKORN
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ORPHENADRINE CITRATE ORPHENADRINE CITRATE 30MG/ML INJECTABLE;INJECTION Prescription AP No Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
05/24/2006 ORIG-1 Approval

Label is not available on this site.

ORPHENADRINE CITRATE

INJECTABLE;INJECTION; 30MG/ML
TE Code = AP

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ORPHENADRINE CITRATE ORPHENADRINE CITRATE 30MG/ML INJECTABLE;INJECTION Prescription No AP 040484 AKORN
ORPHENADRINE CITRATE ORPHENADRINE CITRATE 30MG/ML INJECTABLE;INJECTION Prescription No AP 040463 HIKMA
ORPHENADRINE CITRATE ORPHENADRINE CITRATE 30MG/ML INJECTABLE;INJECTION Prescription No AP 090585 SAGENT PHARMS
ORPHENADRINE CITRATE ORPHENADRINE CITRATE 30MG/ML INJECTABLE;INJECTION Prescription No AP 084779 WATSON LABS
Back to Top